Annual Current Liabilities:
$120.68M+$44.62M(+58.66%)Summary
- As of today, CPRX annual current liabilities is $120.68 million, with the most recent change of +$44.62 million (+58.66%) on December 31, 2024.
 - During the last 3 years, CPRX annual current liabilities has risen by +$93.61 million (+345.92%).
 - CPRX annual current liabilities is now at all-time high.
 
Performance
CPRX Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Current Liabilities:
$113.01M+$1.36M(+1.22%)Summary
- As of today, CPRX quarterly current liabilities is $113.01 million, with the most recent change of +$1.36 million (+1.22%) on June 30, 2025.
 - Over the past year, CPRX quarterly current liabilities has increased by +$20.69 million (+22.41%).
 - CPRX quarterly current liabilities is now -6.36% below its all-time high of $120.68 million, reached on December 31, 2024.
 
Performance
CPRX Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
CPRX Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | 
|---|---|---|
| 1Y1 Year | +58.7% | +22.4% | 
| 3Y3 Years | +345.9% | +402.5% | 
| 5Y5 Years | +400.8% | +459.1% | 
CPRX Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +345.9% | -6.4% | +152.9% | 
| 5Y | 5-Year | at high | +430.3% | -6.4% | +682.8% | 
| All-Time | All-Time | at high | >+9999.0% | -6.4% | >+9999.0% | 
CPRX Current Liabilities History
| Date | Annual | Quarterly | 
|---|---|---|
| Jun 2025 | -  | $113.01M(+1.2%)  | 
| Mar 2025 | -  | $111.65M(-7.5%)  | 
| Dec 2024 | $120.68M(+58.7%)  | $120.68M(+14.5%)  | 
| Sep 2024 | -  | $105.39M(+14.2%)  | 
| Jun 2024 | -  | $92.32M(+16.0%)  | 
| Mar 2024 | -  | $79.57M(+4.6%)  | 
| Dec 2023 | $76.06M(+32.1%)  | $76.06M(+31.6%)  | 
| Sep 2023 | -  | $57.81M(+10.1%)  | 
| Jun 2023 | -  | $52.50M(-7.4%)  | 
| Mar 2023 | -  | $56.71M(-1.5%)  | 
| Dec 2022 | $57.59M(+112.8%)  | $57.59M(+28.9%)  | 
| Sep 2022 | -  | $44.68M(+98.7%)  | 
| Jun 2022 | -  | $22.49M(-2.0%)  | 
| Mar 2022 | -  | $22.94M(-15.2%)  | 
| Dec 2021 | $27.06M(+18.9%)  | $27.06M(+31.3%)  | 
| Sep 2021 | -  | $20.61M(+27.8%)  | 
| Jun 2021 | -  | $16.14M(+11.8%)  | 
| Mar 2021 | -  | $14.44M(-36.6%)  | 
| Dec 2020 | $22.76M(-5.6%)  | $22.76M(+24.8%)  | 
| Sep 2020 | -  | $18.23M(-9.8%)  | 
| Jun 2020 | -  | $20.21M(+14.6%)  | 
| Mar 2020 | -  | $17.64M(-26.8%)  | 
| Dec 2019 | $24.10M(+153.4%)  | $24.10M(+34.0%)  | 
| Sep 2019 | -  | $17.98M(+27.1%)  | 
| Jun 2019 | -  | $14.15M(+56.8%)  | 
| Mar 2019 | -  | $9.03M(-5.1%)  | 
| Dec 2018 | $9.51M(+122.9%)  | $9.51M(+174.2%)  | 
| Sep 2018 | -  | $3.47M(+12.5%)  | 
| Jun 2018 | -  | $3.08M(+12.8%)  | 
| Mar 2018 | -  | $2.73M(-36.0%)  | 
| Dec 2017 | $4.27M(+103.7%)  | $4.27M(+55.8%)  | 
| Sep 2017 | -  | $2.74M(+48.8%)  | 
| Jun 2017 | -  | $1.84M(-3.4%)  | 
| Mar 2017 | -  | $1.91M(-9.0%)  | 
| Dec 2016 | $2.09M(-39.1%)  | $2.09M(+5.0%)  | 
| Sep 2016 | -  | $2.00M(-13.4%)  | 
| Jun 2016 | -  | $2.31M(-13.5%)  | 
| Mar 2016 | -  | $2.66M(-22.6%)  | 
| Dec 2015 | $3.44M  | $3.44M(+44.2%)  | 
| Date | Annual | Quarterly | 
|---|---|---|
| Sep 2015 | -  | $2.39M(-6.5%)  | 
| Jun 2015 | -  | $2.55M(-56.3%)  | 
| Mar 2015 | -  | $5.85M(-0.1%)  | 
| Dec 2014 | $5.86M(+173.6%)  | $5.86M(-1.4%)  | 
| Sep 2014 | -  | $5.94M(+151.2%)  | 
| Jun 2014 | -  | $2.36M(-3.0%)  | 
| Mar 2014 | -  | $2.44M(+13.9%)  | 
| Dec 2013 | $2.14M(+29.9%)  | $2.14M(-29.0%)  | 
| Sep 2013 | -  | $3.01M(+83.9%)  | 
| Jun 2013 | -  | $1.64M(+66.6%)  | 
| Mar 2013 | -  | $983.20K(-40.3%)  | 
| Dec 2012 | $1.65M(+97.5%)  | $1.65M(+118.6%)  | 
| Sep 2012 | -  | $753.30K(+11.3%)  | 
| Jun 2012 | -  | $677.00K(-23.0%)  | 
| Mar 2012 | -  | $879.30K(+5.5%)  | 
| Dec 2011 | $833.80K(+178.9%)  | $833.80K(+97.3%)  | 
| Sep 2011 | -  | $422.70K(-35.6%)  | 
| Jun 2011 | -  | $656.10K(-23.9%)  | 
| Mar 2011 | -  | $862.30K(+188.4%)  | 
| Dec 2010 | $299.00K(+1.6%)  | $299.00K(-24.5%)  | 
| Sep 2010 | -  | $396.10K(-12.2%)  | 
| Jun 2010 | -  | $451.20K(+34.8%)  | 
| Mar 2010 | -  | $334.70K(+13.8%)  | 
| Dec 2009 | $294.20K(-79.4%)  | $294.20K(+10.7%)  | 
| Sep 2009 | -  | $265.70K(-43.6%)  | 
| Jun 2009 | -  | $470.90K(-69.4%)  | 
| Mar 2009 | -  | $1.54M(+7.5%)  | 
| Dec 2008 | $1.43M(+371.5%)  | $1.43M(+17.2%)  | 
| Sep 2008 | -  | $1.22M(+64.9%)  | 
| Jun 2008 | -  | $740.10K(+68.9%)  | 
| Mar 2008 | -  | $438.10K(+44.4%)  | 
| Dec 2007 | $303.30K(-60.8%)  | $303.30K(-25.1%)  | 
| Sep 2007 | -  | $405.10K(-3.2%)  | 
| Jun 2007 | -  | $418.50K(-20.2%)  | 
| Mar 2007 | -  | $524.30K(-32.2%)  | 
| Dec 2006 | $772.80K(+125.3%)  | $772.80K(+12.6%)  | 
| Sep 2006 | -  | $686.50K(+58.0%)  | 
| Jun 2006 | -  | $434.40K(+26.6%)  | 
| Dec 2005 | $343.00K(+405.9%)  | $343.00K(+405.9%)  | 
| Dec 2004 | $67.80K  | $67.80K  | 
FAQ
- What is Catalyst Pharmaceuticals, Inc. annual current liabilities?
 - What is the all-time high annual current liabilities for Catalyst Pharmaceuticals, Inc.?
 - What is Catalyst Pharmaceuticals, Inc. annual current liabilities year-on-year change?
 - What is Catalyst Pharmaceuticals, Inc. quarterly current liabilities?
 - What is the all-time high quarterly current liabilities for Catalyst Pharmaceuticals, Inc.?
 - What is Catalyst Pharmaceuticals, Inc. quarterly current liabilities year-on-year change?
 
What is Catalyst Pharmaceuticals, Inc. annual current liabilities?
The current annual current liabilities of CPRX is $120.68M
What is the all-time high annual current liabilities for Catalyst Pharmaceuticals, Inc.?
Catalyst Pharmaceuticals, Inc. all-time high annual current liabilities is $120.68M
What is Catalyst Pharmaceuticals, Inc. annual current liabilities year-on-year change?
Over the past year, CPRX annual current liabilities has changed by +$44.62M (+58.66%)
What is Catalyst Pharmaceuticals, Inc. quarterly current liabilities?
The current quarterly current liabilities of CPRX is $113.01M
What is the all-time high quarterly current liabilities for Catalyst Pharmaceuticals, Inc.?
Catalyst Pharmaceuticals, Inc. all-time high quarterly current liabilities is $120.68M
What is Catalyst Pharmaceuticals, Inc. quarterly current liabilities year-on-year change?
Over the past year, CPRX quarterly current liabilities has changed by +$20.69M (+22.41%)